WHO ICTRP trial
Hypertesive Patient in Hokuriku area research of Candesartan
JPRN-UMIN000001661 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000001661 |
|---|---|
| Public title | Hypertesive Patient in Hokuriku area research of Candesartan |
| Scientific title | Hypertesive Patient in Hokuriku area research of Candesartan - HAKUSAN |
| Primary sponsor | Ishikawa Internal Medicine Association |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | Japan |
| Conditions | hypertension |
| Interventions | candesartan other ACE-I and/or ARB |
| Registration date | Jan 28, 2009 |
| Target size | 500 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: